body composition is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Updated 2026-07-07. Numbers and descriptions here follow the published literature rather than marketing material.
Trial reports for this compound rely on a small set of repeated measures. Body weight is normally expressed as percent change from baseline at a fixed week, with absolute kilograms given secondarily. Glycemic endpoints include HbA1c, fasting glucose, and, in some protocols, continuous glucose monitoring summaries. Imaging endpoints such as MRI-derived proton density fat fraction quantify liver fat. Standardization matters because a percent change and a categorical responder analysis can tell different stories about the same dataset.
Body composition is assessed with dual-energy X-ray absorptiometry or comparable methods, which separate fat mass from lean mass. Reported losses include both compartments, and the ratio between them is a subject of ongoing analysis rather than a settled result. Waist circumference, blood pressure, and lipid panels are collected as supporting measures. Resting energy expenditure and substrate oxidation are measured in smaller mechanistic studies, where glucagon receptor activity is expected to matter. These substudies are typically short and small, so their findings carry wide uncertainty.
Interpretation depends on study phase and duration. Phase 2 programs are powered for weight and safety signals, not for cardiovascular or renal outcomes, which require event-driven designs. Gastrointestinal events such as nausea, diarrhea, vomiting, and constipation are the most frequently reported adverse effects and tend to cluster around dose escalation. Small increases in heart rate have been described. Because follow-up after treatment discontinuation is limited, questions about weight regain and durability are open rather than answered.
Retatrutide is an investigational synthetic peptide developed under the code LY3437943, with a backbone derived from glucose-dependent insulinotropic polypeptide. Several non-proteinogenic residues, including alpha-aminoisobutyric acid, appear in that backbone, and a fatty diacid side chain attached through a linker extends circulation time. The molecule carries roughly thirty-nine amino acid units and a total mass near 4.7 kilodaltons. Administration is by subcutaneous injection once weekly. Published work uses both the name retatrutide and the code LY3437943.
Pharmacologically the compound activates three receptors: GLP-1, GIP, and glucagon. GLP-1 and GIP signaling contribute to glucose-dependent insulin release, delayed gastric emptying, and reduced appetite, while glucagon receptor activation is associated with increased energy expenditure and hepatic fat oxidation. The single-molecule design is intended to keep these activities in one peptide rather than combining separate agents. Relative activity at each receptor differs, and the balance between them is a central question in interpretation. The glucagon component is partly offset by incretin-mediated insulin secretion, an interaction that remains incompletely characterized.
Development has progressed from single- and multiple-ascending-dose studies in healthy volunteers into larger randomized trials in adults with obesity, type 2 diabetes, and fatty liver disease. Early reports describe dose-dependent reductions in body weight and improvements in glycemic markers over treatment periods of several months. Whether the glucagon arm adds tolerability cost without added benefit is still debated. Long-term cardiovascular outcomes, effects after treatment stops, and performance in older or comorbid populations are open questions rather than settled findings. Approval status may change, so the current investigational label should be confirmed against regulatory sources.
| Property | Value | Notes |
|---|---|---|
| Trial design | Randomized, double-blind, placebo-controlled | Frequently includes dose-escalation arms |
| Weight endpoint | Percent change from baseline | Reported at a prespecified week |
| Liver fat endpoint | MRI proton density fat fraction | Non-invasive imaging measure |
| Body composition method | Dual-energy X-ray absorptiometry | Separates fat mass from lean mass |
| Common adverse events | Nausea, diarrhea, vomiting | Reported most often during dose escalation |
Quantification of the peptide in biological samples generally relies on liquid chromatography coupled with tandem mass spectrometry. This approach separates the analyte from matrix components and detects it by mass-to-charge transitions specific to the molecule. Immunoassays offer higher throughput but can cross-react with related peptides and metabolites, so mass spectrometric methods are preferred when structural confirmation is required. Method validation typically addresses accuracy, precision, selectivity, and stability under handling conditions.
Several questions remain unresolved. It is not yet known whether the compound reduces cardiovascular events or mortality, because outcome studies require long follow-up. The durability of weight reduction after treatment withdrawal is uncertain, and rebound has been observed with other incretin-based therapies. Long-term safety data covering several years are limited. Effects in adolescents, in pregnancy, and in people with significant kidney or liver impairment have not been characterized in published reports.
Retatrutide is an investigational synthetic peptide that acts as an agonist at three distinct G protein-coupled receptors. It combines activity at the glucagon-like peptide-1 receptor, the glucose-dependent insulinotropic polypeptide receptor, and the glucagon receptor within a single molecule. This multi-receptor profile distinguishes it from earlier incretin-based compounds that engage one or two of these pathways. Researchers designed the molecule to test whether simultaneous activation produces greater metabolic effects than single or dual agonism alone.
The peptide backbone is chemically modified to resist rapid enzymatic breakdown in the body. A fatty acid side chain promotes binding to serum albumin, which slows renal clearance and supports an extended circulation time. These modifications allow less frequent administration than would be possible with an unmodified peptide. The precise contribution of glucagon receptor activation to the overall metabolic effect remains an area of active investigation, because glucagon raises glucose while also increasing energy expenditure.
Development has progressed through early- and mid-stage human studies in adults with obesity and with type 2 diabetes. Published phase 2 data reported reductions in body weight and improvements in glycemic markers over the treatment period. No regulatory agency has approved the compound for any indication, and it remains available only within controlled research settings. Whether benefits observed in trials translate into durable outcomes after treatment stops is not yet established.
Angusticanaliculate - Long, narrow, straight pores with low pore density. These eggs would have a low gas exchange rate, and therefore they were typically laid in dry areas. Tubocanaliculate - Large diameter pores with funnel-shaped openings on both inner and outer surfaces of the shell. These eggs would have a high gas exchange rate, and therefore were probably buried in humid mounds. Multicanaliculate - Numerous large, branching, and closely spaced pore canals. They have a high gas exchange rate, so like tubocanaliculate eggs they were probably also buried humid mounds. Prolatocanaliculate - Pores vary in width throughout their length. Gas exchange water loss rates are variable, so these eggs could have been laid in many different environments. This type is subdivided into foveocanaliculate with larger pore openings, and lagenocanaliculate with narrower pore openings. Rimocanaliculate - Very narrow slitlike pore canals. This pore system is seen in modern ostriches, so these eggs were laid in open nests, similar to how ostriches do today. Obliquicanaliculate - These canals cut diagonally through multiple eggshell units instead of going between them like in other pore systems. Obliquicanaliculate pores are only found in a single oogenus: Preprismatoolithus.
In February 1946, George F. Kennan's "Long Telegram" from Moscow to Washington helped to articulate the US government's increasingly hard line against the Soviets, which would become the basis for US strategy toward the Soviet Union. The telegram galvanized a policy debate that would eventually shape the Truman administration's Soviet policy. Washington's opposition to the Soviets accumulated after broken promises by Stalin and Molotov concerning Europe and Iran. Following the World War II Anglo-Soviet invasion of Iran, the country was occupied by the Red Army in the far north and the British in the south. Iran was used by the United States and British to supply the Soviet Union, and the Allies agreed to withdraw from Iran within six months after the cessation of hostilities. However, when this deadline came, the Soviets remained in Iran under the guise of the Azerbaijan People's Government and Kurdish Republic of Mahabad. On 5 March, former British prime minister Winston Churchill delivered his famous "Iron Curtain" speech (Fulton Speech) calling for an Anglo-American alliance against the Soviets, whom he accused of establishing an "iron curtain" dividing Europe.
A March 2020 report by ProPublica revealed that Walmart used its political influence with the Trump administration to avoid criminal prosecution for over-dispensing opioids in Texas. In July 2020, Indivior Solutions, Indivior Inc., and Indivior plc agreed to pay $600 million to resolve liability related to false marketing of Suboxone to MassHealth for use by patients with children under the age of six years old. Additionally, Indivior Solutions pled guilty to one-count of felony information. On December 15, 2025, Trump signed an executive order classifying fentanyl as a "weapon of mass destruction".
Sources: en.wikipedia.org
== Replication == Replication of the R1 plasmid begins at the oriRI site on the plasmid. RepA is the plasma-encoded initiator protein that binds to oriRI in order to initiate replication. RepA needs a 188-bp region of DNA at minimum in order to bind. Initiation of the leading strand, primed by DnaG, occurs at a G-type priming signal. This signal is located 400 bp downstream of the RepA-binding sequences. A newly synthesized RepA protein is used by an oriR on the same template that it was synthesized on, a cis-specific action.
=== Interleukins and obesity === With the discovery of interleukins (IL), the concept of systemic inflammation developed. Although the processes involved are identical to tissue inflammation, systemic inflammation is not confined to a particular tissue but involves the endothelium and other organ systems. Chronic inflammation is widely observed in obesity. Obese people commonly have many elevated markers of inflammation, including:
In order to avoid the stigma of a restaurant chain, Smashburger crafts local burgers for each city where it is located and markets them extensively. These burgers are designed after consulting with distributors for the kinds of ingredients that are most shipped to a particular city or geographic area. For instance, Smashburger's Colorado locations serve burgers with roasted green chiles, while locations in Miami serve burgers with grilled chorizo. In Minneapolis, the chain has a double-cheese, double-onion variety evoking Scandinavian and Germanic cuisine. Its Oklahoma variety features locally popular fried pickles, while Boston locations serve a burger with onions and a cranberry chutney supplied locally by Ocean Spray. The burgers tend to be original creations as opposed to duplicating local flavors; in the case of Minneapolis the chain deliberately avoided selling a burger that would resemble the locally renowned Jucy Lucy. There are exceptions, such as in Kalamazoo and Grand Rapids restaurants, where the local burger is topped with olives, a tradition that had once been locally popular. The restaurant attracted criticism from health experts for the unhealthiness of some of its menu offerings. A large BBQ Bacon and Cheddar Smashburger has 1,050 calories, while a Chocolate Oreo Shake has 950 calories. Initially, the restaurant made only larger burgers and marketed large servings as a value add, but as it grew it began to offer different sizes to appeal to a larger audience.
"Beef was stowed on the larboard side and pork to starboard; flour, rice, and peas/beans in the wings. Stowage, as with the water casks below them, is begun from aft and worked forward. Casks in the spirit room are stowed from the forward bulkhead aft. In all cases, the largest containers are closest to the keelson, with sizes diminishing as they are laid outboard. All casks are laid bung up." Foodstuffs may well be in the hold for months, perhaps years. Two hundred years ago life ashore was tough and life at sea had the advantage that at least you would get three meals a day, however grim they may have been.
Sources: en.wikipedia.org
=== Venetia Berens === Venetia Berens (Indy Lewis) is a new grad who joins Pierpoint's FX desk in the second series. She is first seen in series 1 at a Pierpoint recruiting event, pressing Robert and Yasmin on the firm's toxic culture. Ambitious and idealistic, Venetia is determined to prove herself within Pierpoint's cutthroat work environment, provoking resentment from Yasmin over not having to face the same mistreatment she suffered in her first year. In series 2, While scouting new recruits, Venetia grows closer to Robert, to whom she is attracted, but Robert humiliates her when he makes an aggressive pitch to a student while on cocaine, wherein he suggests that Venetia is merely using achievement to seek external validation. Venetia later barges into a client dinner between Robert and Nicole Craig, unaware that they are in a sexual relationship; after Robert leaves the two alone, Nicole sexually assaults Venetia. Venetia confides this to Yasmin, but she dismisses her concerns. Venetia then goes to Kenny, who attempts to report the assault up the chain of command, but to no avail. In series 3, Venetia and Robert have begun dating. Venetia, growing increasingly tired of Pierpoint's abusive work environment, eventually quits the firm. While leaving, she reveals to Rishi that she was the one who anonymously posted to a Reddit page called "Overheard At Pierpoint", which contained many of Rishi's lewd and inappropriate comments on the trading floor.
In the 19th century, artificial feeding begin to replace wet nursing, and by 1900, wet nursing no longer existed as an organized profession. Changes to the feeding of infants were both socially and technologically driven. With industrialization, more mothers worked outside the home and could less easily breastfeed their children. Technological changes including the design of artificial feeding methods and the preparation of animal milks and other milk substitutes supported a transition to artificial feeding, but with mixed success. Understanding of both nutrition and sanitation lagged behind the introduction of artificial feeding methods, contributing to extremely high infant mortality rates in the Victorian era.
== Symptoms == In AOA1, patients usually experience oculomotor apraxia, problems with innitiation (oculocephalic dissociation) and slowing of saccades, nystagmus, failure of fixation, excessive blinking, ataxia, tremor, neuropathy (which leads to hyporeflexia, diminished sense of vibration, and limb weakness), atrophy of the cerebellum, decreased levels of albumin and elevated levels of cholesterol, dysarthric speech, chorea (which might disappear as disease progresses). Occasionally, patients experience scoliosis, intellectual disability, dystonia, head thrust, elevated levels of creatine kinase and alpha-fetoprotein. Rarely, patients experience parkinsonism, myoclonic jerks, and pyramidal signs. Oculomotor apraxia, head thrust, and oculocephalic dissociation might be associated with much severe form of this disorder. Patients can experience subtle immune abnormalities such as lymphopenia of B- and T- cells (CD4+ and CD8+ T cells are affected), decreased levels of antibodies, low levels of T-cell receptor rearrangement excision circles and immunoglobulin κappa-deleting recombination excision circles, and lymphocytes are mildy sensetive to ionizing radiation.
Sources: en.wikipedia.org
A responder analysis counts participants who cross a threshold, such as five or ten percent weight loss. It complements average percent change by showing how widely results are distributed. The two measures can diverge when a subset of participants loses a large amount.
Mechanistic measures such as energy expenditure and liver fat change come from small substudies and should be read as preliminary. Long-term clinical outcomes are not yet available. Average weight loss figures are better supported than explanations for how the loss is achieved.
Endpoints reported at different weeks, in different baseline BMI ranges, or under different dose-escalation schedules are not directly comparable. Studies in type 2 diabetes often show smaller weight changes than studies in obesity without diabetes. Reporting the population alongside the number keeps comparisons honest.
As of the mid-2020s retatrutide remains investigational and is not an approved medicine in the United States or the European Union. It has been supplied mainly to participants in clinical trials. Labels and availability can change, so regulatory listings should be checked directly.